StemRNA iPSCs: off-the-shelf lines

Human induced Pluripotent Stem Cells

StemRNA™ human iPSCs (a.k.a. hiPSCs) provide immediate access to the state-of-the-art Stemgent StemRNA 3^rd Gen Reprogramming technology. These cells are ideal for validating the StemRNA 3^rd Gen Technology with control cells prior to investing in reprogramming to develop patient-derived cell lines.

Our StemRNA human iPSCs are derived from more than ten healthy and neurodegenerative disease donors with a range of demographic and clinical backgrounds. This means they do not contain vectors, viruses, or DNA – unlike iPSCs created using other reprogramming methods.

StemRNA human iPSCs are research-ready and free for commercial applications*, including vaccine testing and drug screening.
(*Terms & conditions apply.)

  Browse the full range of StemRNA hiPSCs

Benefits of StemRNA human iPSCs

• Ready for use in experiments such as differentiation
  • Reprogrammed using the state of the art StemRNA 3^rd Gen Reprogramming Technology
  • No specialized reprogramming knowledge required
  • No retention or integration of reprogramming vectors
  • Imunologically (ICC) and functionally (teratoma formation) pluripotent
  • Normal karyotype
• Significant time savings
  • Saves 2-4 months or more compared to reprogramming your own iPSCs
• Easy access to iPSCs for start-up labs
  • No specialized reprogramming knowledge required
  • Grows in standard stem cell media and support matrices